1988 - Bachelor's Degree in Medicine: Bengbu Medical College
1999 - Doctorate in Medicine: Shanghai Medical University
2001-2002 - Postdoctoral Research in Molecular Epidemiology: Vanderbilt University
Published over 400 papers, with more than 100 in SCI journals
Authored 12 professional reference books
Received 10 provincial and ministerial science and technology awards
Granted 4 patents
Shanghai Medical Science and Technology Award First Prize
National Hundred, Thousand, and Ten Thousand Talent Project
Outstanding Contribution Young and Middle-aged Expert
Shanghai Science and Technology Progress Award - Popular Science Talent
National Moral Model and Good Doctor of China
Scientific Chinese Person of the Year (2016)
Most Beautiful Foreign Aid Doctor
Influential Person in China (2014) - Science and Technology Figure
Second Shanghai 'Humanitarian and Philanthropy Award'
Shanghai Leading Talent
Shanghai Outstanding Discipline Leader
Shanghai Medical Leading Talent
Shanghai May 1st Labor Medal
Shanghai Health System 'Silver Snake Award'
Shanghai Outstanding Specialist Doctor Award
Medical Craftsman
Civilized Worker
Innovation Star
Outstanding Invention Silver Award
Shanghai Health Bureau Advanced Worker
Meritorious Service Award
Shanghai Science and Technology Commission 'Meiji Dairy Science Award'
American Association for the Study of Liver Diseases - Asia Pacific Association for the Study of the Liver Award
AIDS International Advocacy Alliance 'Loyalty Award'
Research
Diagnosis and treatment of infectious diseases and pathogenesis research
COVID-19: imbalanced cell-mediated immune response drives to immunopathology, Wang J, Li Q, Qiu Y, Lu H, 2022
A feasibility study of Covid-19 detection using breath analysis by high-pressure photon ionization time-of-flight mass spectrometry, Zhang P, Ren T, Lu H, et al., 2022
Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2, Yang Y, Gong X, Lu H, et al., 2022
Monkeypox-A danger approaching Asia, Liu X, Zhu Z, Miao Q, Lim JW, Lu H, 2022
Monkeypox claims new victims: the outbreak in men who have sex with men, Liu X, Zhu Z, Lu H, et al., 2022
Exploring bridge symptoms in HIV-positive people with comorbid depressive and anxiety disorders, Liu X, Wang H, Zhu Z, Zhang L, Cao J, Zhang L, Yang H, Wen H, Hu Y, Chen C, Lu H, 2022
A SARS-CoV-2 antibody retains potent neutralization against Omicron by targeting conserved RBM residues, Yi C, Ling Z, Lu X, Fu Y, Yang Z, Wangmo S, Chen S, Zhang Y, Ma L, Gu W, Lu H, Sun X, Sun B, 2022
Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy: 48-week randomized, controlled, phase 3 non-inferiority TALENT study, Su B, Yao C, Lu H, et al., 2022
Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children, Li X, Wu L, Qu Y, Cao M, Feng J, Huang H, Liu Y, Lu H, Liu Q, Liu Y, 2022
Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression, Yang S, Ling Y, Lu H, et al., 2022
Long-term case-fatality rate of nontuberculous mycobacterial disease in people living with HIV, Hu J, Gu L, Lu H, et al., 2022
Utility of urine lipoarabinomannan (LAM) in diagnosing mycobacteria infection among hospitalized HIV-positive patients, Liu D, Gu L, Zhang R, Liu L, Shen Y, Shao Y, Wang J, Sun J, Qi T, Wang Z, Tang Y, Song W, Xun J, Lu H, Chen J, 2022
SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network, Li W, Yang S, Lu H, et al., 2022
Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees, YangYang, Gong X, Yang L, et al., 2022
Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses, Wang Y, Liu M, Lu H, et al., 2022
The COVID-19-designated hospitals in China: preparing for public health emergencies, Li Q, Wang L, Wang B, Lu H, 2021
Can we use hydroxychloroquine to treat COVID-19 now?, Chen J, Liu D, Yin L, Zhang L, Lu H, 2021
Dynamic anti-spike protein antibody profiles in COVID-19 patients, Bao Y, Ling Y, Lu H, et al., 2021
Clinical usefulness of metagenomic next-generation sequencing for the diagnosis of central nervous system infection in people living with HIV, Chen J, Zhang R, Lu H, et al., 2021
Pathogenesis-directed therapy of 2019 novel coronavirus disease, Stratton CW, Tang YW, Lu H, 2021
Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody, Meng X, Wang P, Xiong Y, Wu Y, Lin X, Lu S, Li R, Zhao B, Liu J, Zeng S, Zeng L, Wu Y, Lu Y, Zhang J, Liu D, Wang S, Lu H, 2021
The role of peripheral blood eosinophil counts in COVID-19 patients, Xie G, Ding F, Han L, Yin D, Lu H, Zhang M, 2021
Saliva specimen complements anal swab in assessing patients with COVID-19 for discharge from hospital, Qiu C, Song Z, Wang J, Tian C, Liu X, Wu T, Li W, Zhang S, Lu H, 2021
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants, Yi C, Sun X, Lin Y, Gu C, Ding L, Lu X, Yang Z, Zhang Y, Ma L, Gu W, Qu A, Zhou X, Li X, Xu J, Ling Z, Xie Y, Lu H, Sun B, 2021
Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19, Tan Y, Zhang W, Zhu Z, Qiao N, Ling Y, Guo M, Yin T, Fang H, Xu X, Lu G, Zhang P, Yang S, Fu Z, Liang D, Xie Y, Zhang R, Jiang L, Yu S, Lu J, Jiang F, Chen J, Xiao C, Wang S, Chen S, Bian XW, Lu H, Liu F, Chen S, 2021
Clinical observation and management of COVID-19 patients, Li T, Lu H, Zhang W, 2020
COVID-19 with Different Severities: A Multicenter Study of Clinical Features, Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, Xiong W, Yang D, Chen R, Lu F, Lu Y, Liu X, Chen Y, Li X, Li Y, Summah HD, Lin H, Yan J, Zhou M, Lu H, Qu J, 2020
Efficacy and safety of lower dose tenofovir disoproxil fumarate and efavirenz versus standard dose in HIV-infected, antiretroviral-naive adults: a multicentre, randomized, noninferiority trial, Chen J, Chen R, Shen Y, Wei H, Wang X, Zhang R, Hu Z, Xie R, Huang Q, Wang J, Liu L, Qi T, Wang Z, Song W, Tang Y, Sun J, Lu H, 2020
Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population, Yi Z, Ling
Keywords
Infectious DiseasesDiagnosisTreatmentPathogenesisResearchEpidemiologyVirologyImmunologyClinical TrialsPublic Health
